Subdivision 1.
MS 2024 [Repealed,2023 c 63 art 6 s 73;2024 c 121 art 2 s 147]
[See Note.]
Subd. 2.
MS 2024 [Repealed,2023 c 63 art 6 s 73;2024 c 121 art 2 s 147]
[See Note.]
Subd. 3.
MS 2024 [Repealed,2023 c 63 art 6 s 73;2024 c 121 art 2 s 147]
[See Note.]
Subd. 3a.
MS 2024 [Repealed,2023 c 63 art 6 s 73;2024 c 121 art 2 s 147]
[See Note.]
Subd. 3b.Distribution to recipient in a motor vehicle.
A manufacturer may distribute medical cannabis to a patient, registered designated caregiver, or parent, legal guardian, or spouse of a patient who is at the distribution facility but remains in a motor vehicle, provided:
(1)distribution facility staff receive payment and distribute medical cannabis in a designated zone that is as close as feasible to the front door of the distribution facilit
Free access — add to your briefcase to read the full text and ask questions with AI
Subdivision 1.
MS 2024 [Repealed,2023 c 63 art 6 s 73;2024 c 121 art 2 s 147]
[See Note.]
Subd. 2.
MS 2024 [Repealed,2023 c 63 art 6 s 73;2024 c 121 art 2 s 147]
[See Note.]
Subd. 3.
MS 2024 [Repealed,2023 c 63 art 6 s 73;2024 c 121 art 2 s 147]
[See Note.]
Subd. 3a.
MS 2024 [Repealed,2023 c 63 art 6 s 73;2024 c 121 art 2 s 147]
[See Note.]
Subd. 3b.Distribution to recipient in a motor vehicle.
A manufacturer may distribute medical cannabis to a patient, registered designated caregiver, or parent, legal guardian, or spouse of a patient who is at the distribution facility but remains in a motor vehicle, provided:
(1) distribution facility staff receive payment and distribute medical cannabis in a designated zone that is as close as feasible to the front door of the distribution facility;
(2) the manufacturer ensures that the receipt of payment and distribution of medical cannabis are visually recorded by a closed-circuit television surveillance camera at the distribution facility and provides any other necessary security safeguards;
(3) the manufacturer does not store medical cannabis outside a restricted access area at the distribution facility, and distribution facility staff transport medical cannabis from a restricted access area at the distribution facility to the designated zone for distribution only after confirming that the patient, designated caregiver, or parent, guardian, or spouse has arrived in the designated zone;
(4) the payment and distribution of medical cannabis take place only after a pharmacist consultation takes place, if required under subdivision 3, paragraph (c), clause (4);
(5) immediately following distribution of medical cannabis, distribution facility staff enter the transaction in the state medical cannabis registry information technology database; and
(6) immediately following distribution of medical cannabis, distribution facility staff take the payment received into the distribution facility.
Subd. 3c.Disposal of medical cannabis plant root balls.
Notwithstanding Minnesota Rules, part4770.1200, subpart 2, item C, a manufacturer is not required to grind root balls of medical cannabis plants or incorporate them with a greater quantity of nonconsumable solid waste before transporting root balls to another location for disposal. For purposes of this subdivision, "root ball" means a compact mass of roots formed by a plant and any attached growing medium.
Subd. 4.
MS 2024 [Repealed,2023 c 63 art 6 s 73;2024 c 121 art 2 s 147]
[See Note.]
Subd. 5.Distribution to Tribal medical cannabis program patient.
(a) A manufacturer may distribute medical cannabis in accordance with subdivisions 1 to 4 to a Tribal medical cannabis program patient.
(b) Prior to distribution, the Tribal medical cannabis program patient must provide to the manufacturer:
(1) a valid medical cannabis registration verification card or equivalent document issued by a Tribal medical cannabis program that indicates that the Tribal medical cannabis program patient is authorized to use medical cannabis on Indian lands over which the Tribe has jurisdiction; and
(2) a valid photographic identification card issued by the Tribal medical cannabis program, a valid driver's license, or a valid state identification card.
(c) A manufacturer shall distribute medical cannabis to a Tribal medical cannabis program patient only in a form allowed under section152.22, subdivision 6.